Literature DB >> 22646276

Biospecimens and biorepositories for the community pathologist.

Rajesh C Dash1, James A Robb, David L Booker, Wen-Chi Foo, David L Witte, Lynn Bry.   

Abstract

Pathologists have long served as custodians of human biospecimens collected for diagnostic purposes. Rapid advancements in diagnostic technologies require that pathologists change their practices to optimize patient care. The proper handling of biospecimens creates opportunities for pathologists to improve their diagnoses while assessing prognosis and treatment. In addition, the growing need for high-quality biorepositories represents an opportunity for community pathologists to strengthen their role within the health care team, ensuring that clinical care is not compromised while facilitating research. This article provides a resource to community pathologists learning how to create high-quality biorepositories and participating in emerging opportunities in the biorepository field. While a variety of topics are covered to provide breadth of information, the intent is to facilitate a level of understanding that permits community pathologists to make more informed choices in identifying how best their skills and practice may be augmented to address developments in this field.

Entities:  

Mesh:

Year:  2012        PMID: 22646276      PMCID: PMC3679406          DOI: 10.5858/arpa.2011-0274-SO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

Review 1.  Effect of fixatives and tissue processing on the content and integrity of nucleic acids.

Authors:  Mythily Srinivasan; Daniel Sedmak; Scott Jewell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

Authors:  Patrick J Roberts; Thomas E Stinchcombe; Channing J Der; Mark A Socinski
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

Review 3.  Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?

Authors:  Massimo Breccia; Fabio Efficace; Giuliana Alimena
Journal:  Cancer Lett       Date:  2010-11-12       Impact factor: 8.679

4.  The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

Authors:  Linda Paavilainen; Asa Edvinsson; Anna Asplund; Sophia Hober; Caroline Kampf; Fredrik Pontén; Kenneth Wester
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

5.  Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.

Authors:  Patrick L Fitzgibbons; Douglas A Murphy; M Elizabeth H Hammond; D Craig Allred; Paul N Valenstein
Journal:  Arch Pathol Lab Med       Date:  2010-06       Impact factor: 5.534

Review 6.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

Review 7.  A new era in the treatment of melanoma: from biology to clinical practice.

Authors:  I Márquez-Rodas; S Martín Algarra; J A Avilés Izquierdo; S Custodio Cabello; M Martín
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

Review 8.  Trastuzumab: in HER2-positive metastatic gastric cancer.

Authors:  Jamie D Croxtall; Kate McKeage
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

9.  A tissue fixative that protects macromolecules (DNA, RNA, and protein) and histomorphology in clinical samples.

Authors:  Vladimir Vincek; Mehdi Nassiri; Mehrdad Nadji; Azorides R Morales
Journal:  Lab Invest       Date:  2003-10       Impact factor: 5.662

Review 10.  Differentiation therapy of acute myeloid leukemia: past, present and future.

Authors:  Kevin Petrie; Arthur Zelent; Samuel Waxman
Journal:  Curr Opin Hematol       Date:  2009-03       Impact factor: 3.284

View more
  6 in total

Review 1.  Proceedings of the 1st Puerto Rico Biobanking Workshop.

Authors:  Edna Mora; James A Robb; Gustavo Stefanoff; Robert Hunter Mellado; Domenico Coppola; Teresita Muñoz-Antonia; Idhaliz Flores
Journal:  Rev Recent Clin Trials       Date:  2014

2.  The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years.

Authors:  Shannon J McCall; Philip A Branton; Victoria M Blanc; Sarah M Dry; Julie M Gastier-Foster; James H Harrison; Scott D Jewell; Rajesh C Dash; Rebecca C Obeng; Joan Rose; Dawna L Mateski; Albi Liubinskas; James A Robb; Nilsa C Ramirez; Kathi Shea
Journal:  Biopreserv Biobank       Date:  2018-02-02       Impact factor: 2.300

3.  A call to standardize preanalytic data elements for biospecimens.

Authors:  James A Robb; Margaret L Gulley; Patrick L Fitzgibbons; Mary F Kennedy; L Mark Cosentino; Kay Washington; Rajesh C Dash; Philip A Branton; Scott D Jewell; Rosanna L Lapham
Journal:  Arch Pathol Lab Med       Date:  2013-08-12       Impact factor: 5.534

4.  Cancer oriented biobanks: A comprehensive review.

Authors:  Shankargouda Patil; Barnali Majumdar; Kamran Habib Awan; Gargi S Sarode; Sachin C Sarode; Amol R Gadbail; Shailesh Gondivkar
Journal:  Oncol Rev       Date:  2018-05-11

5.  How Semantics Connotations May Influence Concerns About Donation of Biospecimens.

Authors:  Stacey A Page; Beverly Anne Collisson; Jenny Godley; Danny Nguyen; Luanne Metz; Daniel Muruve
Journal:  Biopreserv Biobank       Date:  2020-11-11       Impact factor: 2.256

6.  Structured Annual Faculty Review Program Accelerates Professional Development and Promotion: Long-Term Experience of the Duke University Medical Center's Pathology Department.

Authors:  Stanley J Robboy; Roger McLendon
Journal:  Acad Pathol       Date:  2017-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.